Back to results
TerminatedPhase 1

Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer

NCT02524951

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

CFAM / Monter Cancer Center

Lake Success, New York, United States

View on ClinicalTrials.gov
Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer — TrialFind